Medical experts in Sheffield have hailed as a "game changer" trials of a drug that could reduce the recurrence of bladder ...

Overall survival at two years was 82.2% in the durvalumab group and 75.2% in the comparator group. Durvalumab (brand name ...

The study found that patients with muscle-invasive bladder cancer had significantly less risk of cancer progressing or ...

Symptoms to look out for and when to see a doctor - There are roughly 10,000 people a year diagnosed with bladder cancer in ...

A phase 3 clinical trial has shown that patients were 32 per cent less likely to experience cancer recurrence when treated ...

They hope it will be approved by the Medicines and Healthcare Products Regulatory Agency to become the new standard of care.

Immunotherapy is a modern approach to cancer treatment that uses a patient's own immune system to help fight tumors.

Bladder cancer presents through various symptoms, ranging from subtle changes to more noticeable signs. While some symptoms ...

A lung cancer drug already available on the NHS has been proven to cut bladder cancer deaths and reduce the risk of the ...

Immunotherapy is a modern approach to cancer treatment that uses a patient’s own immune system to help fight tumors. It has ...

If approved, Pfizer’s sasanlimab will distinguish itself from Merck’s blockbuster Keytruda as the first PD-1 inhibitor ...

A new artificial intelligence-powered tool called MISO (Multi-modal Spatial Omics) can detect cell-level characteristics of cancer by looking at data from extremely small pieces of tissue—some as ...